Impella in cardiogenic shock; who and when?

doi:10.1016/j.carrev.2020.02.008

PMID: 32247564DOI: 10.1016/j.carrev.2020.02.008Apr 6, 2020Paper

Impella in cardiogenic shock; who and when?

Cardiovascular Revascularization Medicine : Including Molecular Interventions

María Monteagudo-Vela, Vasileios Panoulas

Abstract

No abstract listed.

Citations

Outcomes of heart transplantation in patients bridged with Impella 5.0: Comparison with native chest transplanted patients without preoperative mechanical circulatory support.

Sep 17, 2020·Artificial Organs·María Monteagudo-VelaAndre Rudiger Simon

❮ Previous

Next ❯

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Impella in cardiogenic shock; who and when?

Abstract

Citations

Outcomes of heart transplantation in patients bridged with Impella 5.0: Comparison with native chest transplanted patients without preoperative mechanical circulatory support.

Related Concepts

Related Feeds

Cardiogenic Shock

Related Papers

Improving Survival in Cardiogenic Shock: Is Impella the Answer?

Secular Trend in the Use and Implementation of Impella in High-Risk Percutaneous Coronary Intervention and Cardiogenic Shock: A Real-World Experience

Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience

Myocardial infarction complicated by cardiogenic shock: a possible role for the Impella device?

Use of the Impella Device for Acute Coronary Syndrome Complicated by Cardiogenic Shock - Experience From a Single Heart Center With Analysis of Long-term Mortality